As of May 23
| +1.22 / +1.07%|
The 7 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 141.00, with a high estimate of 162.00 and a low estimate of 129.00. The median estimate represents a +22.64% increase from the last price of 114.97.
The current consensus among 7 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.